BIOTIME INC (13)

Browse by Contract Category

Contracts

Separation and Consulting Agreement dated January 20, 2021 between Registrant and Brandi Roberts (Filed With SEC on March 11, 2021)
Description of Capital Stock of the Registrant (Filed With SEC on March 11, 2021)
Lease Termination Agreement dated September 11, 2020 (Filed With SEC on September 14, 2020)
Second Amendment to Clinical Trial and Option Agreement dated May 6, 2020 between Cancer Research UK, Cancer Research Technology Limited (CRT), Asterias Biotherapeutics, Inc. and... (Filed With SEC on August 6, 2020)
Agreement dated May 6, 2020 between CRT and Registrant (Filed With SEC on August 6, 2020)
2012 Plan Form of Restricted Stock Unit (Filed With SEC on March 12, 2020)
Description of Capital Stock of the Registrant (Filed With SEC on March 12, 2020)
Employment Agreement effective May 20, 2019, between Registrant and Chase Leavitt (Filed With SEC on March 12, 2020)
Amendment to 2012 Equity Incentive Plan (Filed With SEC on November 12, 2019)
Form of Stock Option Agreement under 2012 Equity Incentive Plan (Filed With SEC on November 12, 2019)
Employment Agreement, dated March 18, 2019, between BioTime, Inc. and Edward D. Wirth, III (Filed With SEC on May 9, 2019)
Inducement Option Grant Agreement for Brian Culley (Filed With SEC on March 14, 2019)
Employment Agreement, effective January 7, 2019, between BioTime, Inc. and Brandi Roberts (Filed With SEC on March 14, 2019)